SynBiotic SE Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-10.89	-11.74	-26	-13.07	-0.88
Depreciation & Amortization	8.42	4.55	18.51	8.32	0.12
Other Adjustments	0.23	3.25	0.75	0.09	0.05
Changes in Inventories	-0.17	0.6	0.19	0.26	-0.25
Changes in Accounts Payable	1.84	0.34	-0.29	-0.84	-0.28
Changes in Income Taxes Payable	0.06	0.07	-0.16	0.1	-0.03
Operating Cash Flow	-0.5	-2.92	-7	-5.14	-1.26
Capital Expenditures	-0.15	-0.02	-0.28	-0.37	-0.02
Sale of Property, Plant & Equipment	0.01	-	0.03	-	0
Purchases of Intangible Assets	-0.07	-	-0.2	-	-2.12
Purchases of Investments	-1.85	-0.71	-0.81	-2.97	-0.72
Proceeds from Sale of Investments	-	-	1	-	-
Other Investing Activities	0.18	-	0.19	0.27	1.73
Investing Cash Flow	-2.06	-0.73	-0.07	-3.06	-1.13
Long-Term Debt Issued	4.64	1.37	1.81	1.23	0.37
Long-Term Debt Repaid	-2.12	-1.59	-1.03	-2.79	-
Net Long-Term Debt Issued (Repaid)	2.52	-0.22	0.78	-1.55	0.37
Issuance of Common Stock	0.37	3.16	4.2	7.01	8
Net Common Stock Issued (Repurchased)	0.37	3.16	4.2	7.01	8
Other Financing Activities	-0.05	-0.15	-0.16	-0.05	-
Financing Cash Flow	2.84	2.78	4.83	5.42	8.37
Net Cash Flow	0.45	-0.88	-2.24	-2.79	5.98
Free Cash Flow	-0.65	-2.94	-7.27	-5.51	-1.28
FCF Margin	-4.40%	-72.23%	-83.84%	-60.79%	-23.41%
Free Cash Flow Per Share	-0.11	-0.62	-1.78	-1.80	-0.82
Levered Free Cash Flow	2.81	-5.31	-5.61	-6.81	-0.96
Unlevered Free Cash Flow	-0.57	-6.33	-8.14	-4.28	-1.26